Organon
E554058
Organon is a global pharmaceutical company specializing in women's health, biosimilars, and established medicines, formed as a spin-off from Merck & Co.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Organon canonical | 2 |
How this entity was disambiguated
This entity first appeared as the object of triple T5893199 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Organon Context triple: [Oss, hasCompany, Organon]
-
A.
Organon
Organon is the traditional collection of Aristotle’s works on logic, which laid the foundation for formal logical theory in Western philosophy.
-
B.
Enchiridion
Enchiridion is a concise Stoic handbook attributed to the Greek philosopher Epictetus, offering practical guidance on ethics and personal conduct.
-
C.
Quaestiones ad Thalassium
Quaestiones ad Thalassium is a collection of theological questions and answers traditionally attributed to the early Christian monk and theologian Maximus the Confessor.
-
D.
Miscellanea Analytica
Miscellanea Analytica is a seminal 18th-century mathematical treatise by Abraham de Moivre that develops advanced methods in analysis and probability theory.
-
E.
New Organon
New Organon is a foundational philosophical work by Francis Bacon that proposes a new method of scientific inquiry based on empirical observation and inductive reasoning.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Organon Target entity description: Organon is a global pharmaceutical company specializing in women's health, biosimilars, and established medicines, formed as a spin-off from Merck & Co.
-
A.
Organon
Organon is the traditional collection of Aristotle’s works on logic, which laid the foundation for formal logical theory in Western philosophy.
-
B.
Enchiridion
Enchiridion is a concise Stoic handbook attributed to the Greek philosopher Epictetus, offering practical guidance on ethics and personal conduct.
-
C.
Quaestiones ad Thalassium
Quaestiones ad Thalassium is a collection of theological questions and answers traditionally attributed to the early Christian monk and theologian Maximus the Confessor.
-
D.
Miscellanea Analytica
Miscellanea Analytica is a seminal 18th-century mathematical treatise by Abraham de Moivre that develops advanced methods in analysis and probability theory.
-
E.
New Organon
New Organon is a foundational philosophical work by Francis Bacon that proposes a new method of scientific inquiry based on empirical observation and inductive reasoning.
- F. None of above. chosen
Statements (38)
| Predicate | Object |
|---|---|
| instanceOf |
pharmaceutical company
ⓘ
public company ⓘ |
| alsoKnownAs |
Organon & Co.
ⓘ
linked to:
Organon & Co. (historical, later spun off)
|
| coreTherapeuticArea |
biosimilars
ⓘ
established brands ⓘ women's health ⓘ |
| corporateForm | publicly traded corporation ⓘ |
| countryOfHeadquarters |
United States
ⓘ
linked to:
United States of America
|
| focusesOn |
access to medicines for women
ⓘ
expanding global reach of established brands ⓘ |
| formedBy | corporate spin-off ⓘ |
| hasBusinessFocus |
biosimilar immunology products
ⓘ
biosimilar oncology products ⓘ cardiovascular medicines ⓘ contraception ⓘ fertility treatments ⓘ pain management medicines ⓘ reproductive health ⓘ respiratory medicines ⓘ |
| hasGlobalPresence | yes ⓘ |
| hasOrigin | reorganization of Merck & Co. business units ⓘ |
| hasStrategicPriority |
growth in biosimilars market
ⓘ
maximizing value of established medicines portfolio ⓘ women-centered healthcare solutions ⓘ |
| industry | pharmaceuticals ⓘ |
| operatesInSector | healthcare ⓘ |
| operatesInSubsector | pharmaceutical manufacturing ⓘ |
| parentCompanySpinOffFrom | Merck & Co. ⓘ |
| productPortfolioIncludes |
biosimilar medicines
ⓘ
branded pharmaceuticals ⓘ legacy medicines ⓘ |
| servesMarket | global ⓘ |
| specializesIn |
biosimilars
ⓘ
established medicines ⓘ women's health ⓘ |
| spinOffFrom | Merck & Co. ⓘ |
| stockExchangeListing | New York Stock Exchange ⓘ |
| tickerSymbol | OGN ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Organon Description of subject: Organon is a global pharmaceutical company specializing in women's health, biosimilars, and established medicines, formed as a spin-off from Merck & Co.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.